Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07856667 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease

Study acronym: COINCIDE
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor New version filed on ClinicalTrials.gov
  2. Minor Study First Submitted
8,786 trials monitored
See 412 trials at risk
1,119 trials monitored
See 34 trials at risk
956 trials monitored
See 34 trials at risk
Patients with chronic obstructive pulmonary disease (COPD) and severe asthma frequently present with cardiovascular comorbidities that contribute substantially to morbidity and mortality. Early identification and appropriate management of cardiovascular disease are increasingly recognized as important components of comprehensive care for patients with obstructive airway diseases. The COINCIDE study is a prospective longitudinal observational cohort study conducted at the Department of Pulmonology, Medical University of Innsbruck. The study aims to systematically document cardiovascular comorbidities in patients with COPD and severe asthma and to evaluate their association with disease progression, therapeutic management, exacerbation rates, symptom burden, and pulmonary function over time. Clinical, functional, laboratory, and imaging data obtained as part of routine clinical care will be collected prospectively during two study visits separated by approximately 24 months. Up to 350 adult participants will be enrolled and followed over a period of five years.
Trial Details
NCT Number NCT07856667
Lead Sponsor VASCage GmbH
Conditions
(from sponsor)
Chronic Obstructive Pulmonary Disease (COPD), Severe Asthma, Cardiovascular Diseases
Related terms Asthma, Cardiovascular Diseases, Pulmonary Disease, Chronic Obstructive
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov